Global Antibiotics Active Pharmaceutical Ingredient Market

Antibiotics Active Pharmaceutical Ingredient Comprehensive Study by Type (Penicillin Antibiotics, Cephalosporins, Carbapenem Antibiotics), Application (Pharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Development & Manufacturing Organizations (CDMOs)) Players and Region - Global Market Outlook to 2026

Antibiotics Active Pharmaceutical Ingredient Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Antibiotics Active Pharmaceutical Ingredient Market?

Antibiotic is a type of antimicrobial substance medicines that fights bacterial infections in people and animals. The antibiotic-active pharmaceutical ingredient is the biologically active component of an antibiotic drug product (tablet, capsule, cream, injectable) that produces the intended effects. The factors such as Increased Prevalence of Bacterial Diseases, Increasing Importance of Generics and Upsurge in Novel Drug Applications are the key drivers for the global Antibiotics Active Pharmaceutical Ingredient market. In addition, Increased Research and Development Activities also fueling the market growth. However, High Manufacturing Costs may hamper the market growth.

The market study is being classified by Type (Penicillin Antibiotics, Cephalosporins and Carbapenem Antibiotics), by Application (Pharmaceutical Companies, Contract Manufacturing Organizations (CMOs) and Contract Development & Manufacturing Organizations (CDMOs)) and major geographies with country level break-up.

Sandoz International GmbH (Germany), Centrient Pharmaceuticals (The Netherlands), CordenPharma International (Germany), ACS Dobfar S.p.A. (Italy), Nanjing Dorra Pharmaceutical Technology Co. Ltd. (China), Daewoong Pharmaceutical Co., Ltd (South Korea), Parabolic Drugs Ltd. (India), Penam Laboratories Ltd. (India), Asiatic Drugs & Pharmaceuticals (India), Fresenius Kabi (Germany) and United Laboratories Internat (Hong Kong) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Aurobindo Pharma Limited (India), Unimark Remedies Ltd. (India) and Savior Lifetec Corporation (Taiwan).

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that Indian Players will contribute to the maximum growth of Global Antibiotics Active Pharmaceutical Ingredient market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Antibiotics Active Pharmaceutical Ingredient market by Type, Application and Region.

On the basis of geography, the market of Antibiotics Active Pharmaceutical Ingredient has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Prevalence of Bacterial Diseases
  • Increasing Importance of Generics
  • Upsurge in Novel Drug Applications

Market Trend
  • Increased Research and Development Activities

Restraints
  • High Manufacturing Costs

Opportunities
  • Highly Potent Active Pharmaceutical Ingredient
  • Growth in the Pharmaceutical Industry

Challenges
  • Unfavorable Drug Price Control Policies





Key Target Audience
Antibiotics Active Pharmaceutical Ingredient Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users

Report Objectives / Segmentation Covered

By Type
  • Penicillin Antibiotics
  • Cephalosporins
  • Carbapenem Antibiotics
By Application
  • Pharmaceutical Companies
  • Contract Manufacturing Organizations (CMOs)
  • Contract Development & Manufacturing Organizations (CDMOs)
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Bacterial Diseases
      • 3.2.2. Increasing Importance of Generics
      • 3.2.3. Upsurge in Novel Drug Applications
    • 3.3. Market Challenges
      • 3.3.1. Unfavorable Drug Price Control Policies
    • 3.4. Market Trends
      • 3.4.1. Increased Research and Development Activities
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antibiotics Active Pharmaceutical Ingredient, by Type, Application and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Antibiotics Active Pharmaceutical Ingredient (Value)
      • 5.2.1. Global Antibiotics Active Pharmaceutical Ingredient by: Type (Value)
        • 5.2.1.1. Penicillin Antibiotics
        • 5.2.1.2. Cephalosporins
        • 5.2.1.3. Carbapenem Antibiotics
      • 5.2.2. Global Antibiotics Active Pharmaceutical Ingredient by: Application (Value)
        • 5.2.2.1. Pharmaceutical Companies
        • 5.2.2.2. Contract Manufacturing Organizations (CMOs)
        • 5.2.2.3. Contract Development & Manufacturing Organizations (CDMOs)
      • 5.2.3. Global Antibiotics Active Pharmaceutical Ingredient Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Antibiotics Active Pharmaceutical Ingredient: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sandoz International GmbH (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Centrient Pharmaceuticals (The Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. CordenPharma International (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. ACS Dobfar S.p.A. (Italy)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nanjing Dorra Pharmaceutical Technology Co. Ltd. (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Daewoong Pharmaceutical Co., Ltd (South Korea)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Parabolic Drugs Ltd. (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Penam Laboratories Ltd. (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Asiatic Drugs & Pharmaceuticals (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Fresenius Kabi (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. United Laboratories Internat (Hong Kong)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Antibiotics Active Pharmaceutical Ingredient Sale, by Type, Application and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Antibiotics Active Pharmaceutical Ingredient (Value)
      • 7.2.1. Global Antibiotics Active Pharmaceutical Ingredient by: Type (Value)
        • 7.2.1.1. Penicillin Antibiotics
        • 7.2.1.2. Cephalosporins
        • 7.2.1.3. Carbapenem Antibiotics
      • 7.2.2. Global Antibiotics Active Pharmaceutical Ingredient by: Application (Value)
        • 7.2.2.1. Pharmaceutical Companies
        • 7.2.2.2. Contract Manufacturing Organizations (CMOs)
        • 7.2.2.3. Contract Development & Manufacturing Organizations (CDMOs)
      • 7.2.3. Global Antibiotics Active Pharmaceutical Ingredient Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antibiotics Active Pharmaceutical Ingredient: by Type(USD Million)
  • Table 2. Antibiotics Active Pharmaceutical Ingredient Penicillin Antibiotics , by Region USD Million (2015-2020)
  • Table 3. Antibiotics Active Pharmaceutical Ingredient Cephalosporins , by Region USD Million (2015-2020)
  • Table 4. Antibiotics Active Pharmaceutical Ingredient Carbapenem Antibiotics , by Region USD Million (2015-2020)
  • Table 5. Antibiotics Active Pharmaceutical Ingredient: by Application(USD Million)
  • Table 6. Antibiotics Active Pharmaceutical Ingredient Pharmaceutical Companies , by Region USD Million (2015-2020)
  • Table 7. Antibiotics Active Pharmaceutical Ingredient Contract Manufacturing Organizations (CMOs) , by Region USD Million (2015-2020)
  • Table 8. Antibiotics Active Pharmaceutical Ingredient Contract Development & Manufacturing Organizations (CDMOs) , by Region USD Million (2015-2020)
  • Table 9. South America Antibiotics Active Pharmaceutical Ingredient, by Country USD Million (2015-2020)
  • Table 10. South America Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 11. South America Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 12. Brazil Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 13. Brazil Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 14. Argentina Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 15. Argentina Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 16. Rest of South America Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 17. Rest of South America Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 18. Asia Pacific Antibiotics Active Pharmaceutical Ingredient, by Country USD Million (2015-2020)
  • Table 19. Asia Pacific Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 20. Asia Pacific Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 21. China Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 22. China Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 23. Japan Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 24. Japan Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 25. India Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 26. India Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 27. South Korea Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 28. South Korea Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 29. Taiwan Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 30. Taiwan Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 31. Australia Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 32. Australia Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 33. Rest of Asia-Pacific Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 34. Rest of Asia-Pacific Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 35. Europe Antibiotics Active Pharmaceutical Ingredient, by Country USD Million (2015-2020)
  • Table 36. Europe Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 37. Europe Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 38. Germany Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 39. Germany Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 40. France Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 41. France Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 42. Italy Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 43. Italy Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 44. United Kingdom Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 45. United Kingdom Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 46. Netherlands Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 47. Netherlands Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 48. Rest of Europe Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 49. Rest of Europe Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 50. MEA Antibiotics Active Pharmaceutical Ingredient, by Country USD Million (2015-2020)
  • Table 51. MEA Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 52. MEA Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 53. Middle East Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 54. Middle East Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 55. Africa Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 56. Africa Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 57. North America Antibiotics Active Pharmaceutical Ingredient, by Country USD Million (2015-2020)
  • Table 58. North America Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 59. North America Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 60. United States Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 61. United States Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 62. Canada Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 63. Canada Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 64. Mexico Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2015-2020)
  • Table 65. Mexico Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2015-2020)
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Antibiotics Active Pharmaceutical Ingredient: by Type(USD Million)
  • Table 78. Antibiotics Active Pharmaceutical Ingredient Penicillin Antibiotics , by Region USD Million (2021-2026)
  • Table 79. Antibiotics Active Pharmaceutical Ingredient Cephalosporins , by Region USD Million (2021-2026)
  • Table 80. Antibiotics Active Pharmaceutical Ingredient Carbapenem Antibiotics , by Region USD Million (2021-2026)
  • Table 81. Antibiotics Active Pharmaceutical Ingredient: by Application(USD Million)
  • Table 82. Antibiotics Active Pharmaceutical Ingredient Pharmaceutical Companies , by Region USD Million (2021-2026)
  • Table 83. Antibiotics Active Pharmaceutical Ingredient Contract Manufacturing Organizations (CMOs) , by Region USD Million (2021-2026)
  • Table 84. Antibiotics Active Pharmaceutical Ingredient Contract Development & Manufacturing Organizations (CDMOs) , by Region USD Million (2021-2026)
  • Table 85. South America Antibiotics Active Pharmaceutical Ingredient, by Country USD Million (2021-2026)
  • Table 86. South America Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 87. South America Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 88. Brazil Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 89. Brazil Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 90. Argentina Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 91. Argentina Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 92. Rest of South America Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 93. Rest of South America Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 94. Asia Pacific Antibiotics Active Pharmaceutical Ingredient, by Country USD Million (2021-2026)
  • Table 95. Asia Pacific Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 96. Asia Pacific Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 97. China Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 98. China Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 99. Japan Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 100. Japan Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 101. India Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 102. India Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 103. South Korea Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 104. South Korea Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 105. Taiwan Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 106. Taiwan Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 107. Australia Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 108. Australia Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 109. Rest of Asia-Pacific Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 110. Rest of Asia-Pacific Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 111. Europe Antibiotics Active Pharmaceutical Ingredient, by Country USD Million (2021-2026)
  • Table 112. Europe Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 113. Europe Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 114. Germany Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 115. Germany Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 116. France Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 117. France Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 118. Italy Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 119. Italy Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 120. United Kingdom Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 121. United Kingdom Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 122. Netherlands Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 123. Netherlands Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 124. Rest of Europe Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 125. Rest of Europe Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 126. MEA Antibiotics Active Pharmaceutical Ingredient, by Country USD Million (2021-2026)
  • Table 127. MEA Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 128. MEA Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 129. Middle East Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 130. Middle East Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 131. Africa Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 132. Africa Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 133. North America Antibiotics Active Pharmaceutical Ingredient, by Country USD Million (2021-2026)
  • Table 134. North America Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 135. North America Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 136. United States Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 137. United States Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 138. Canada Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 139. Canada Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 140. Mexico Antibiotics Active Pharmaceutical Ingredient, by Type USD Million (2021-2026)
  • Table 141. Mexico Antibiotics Active Pharmaceutical Ingredient, by Application USD Million (2021-2026)
  • Table 142. Research Programs/Design for This Report
  • Table 143. Key Data Information from Secondary Sources
  • Table 144. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antibiotics Active Pharmaceutical Ingredient: by Type USD Million (2015-2020)
  • Figure 5. Global Antibiotics Active Pharmaceutical Ingredient: by Application USD Million (2015-2020)
  • Figure 6. South America Antibiotics Active Pharmaceutical Ingredient Share (%), by Country
  • Figure 7. Asia Pacific Antibiotics Active Pharmaceutical Ingredient Share (%), by Country
  • Figure 8. Europe Antibiotics Active Pharmaceutical Ingredient Share (%), by Country
  • Figure 9. MEA Antibiotics Active Pharmaceutical Ingredient Share (%), by Country
  • Figure 10. North America Antibiotics Active Pharmaceutical Ingredient Share (%), by Country
  • Figure 11. Global Antibiotics Active Pharmaceutical Ingredient share by Players 2020 (%)
  • Figure 12. Global Antibiotics Active Pharmaceutical Ingredient share by Players (Top 3) 2020(%)
  • Figure 13. Global Antibiotics Active Pharmaceutical Ingredient share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Sandoz International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 16. Sandoz International GmbH (Germany) Revenue: by Geography 2020
  • Figure 17. Centrient Pharmaceuticals (The Netherlands) Revenue, Net Income and Gross profit
  • Figure 18. Centrient Pharmaceuticals (The Netherlands) Revenue: by Geography 2020
  • Figure 19. CordenPharma International (Germany) Revenue, Net Income and Gross profit
  • Figure 20. CordenPharma International (Germany) Revenue: by Geography 2020
  • Figure 21. ACS Dobfar S.p.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 22. ACS Dobfar S.p.A. (Italy) Revenue: by Geography 2020
  • Figure 23. Nanjing Dorra Pharmaceutical Technology Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 24. Nanjing Dorra Pharmaceutical Technology Co. Ltd. (China) Revenue: by Geography 2020
  • Figure 25. Daewoong Pharmaceutical Co., Ltd (South Korea) Revenue, Net Income and Gross profit
  • Figure 26. Daewoong Pharmaceutical Co., Ltd (South Korea) Revenue: by Geography 2020
  • Figure 27. Parabolic Drugs Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 28. Parabolic Drugs Ltd. (India) Revenue: by Geography 2020
  • Figure 29. Penam Laboratories Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 30. Penam Laboratories Ltd. (India) Revenue: by Geography 2020
  • Figure 31. Asiatic Drugs & Pharmaceuticals (India) Revenue, Net Income and Gross profit
  • Figure 32. Asiatic Drugs & Pharmaceuticals (India) Revenue: by Geography 2020
  • Figure 33. Fresenius Kabi (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Fresenius Kabi (Germany) Revenue: by Geography 2020
  • Figure 35. United Laboratories Internat (Hong Kong) Revenue, Net Income and Gross profit
  • Figure 36. United Laboratories Internat (Hong Kong) Revenue: by Geography 2020
  • Figure 37. Global Antibiotics Active Pharmaceutical Ingredient: by Type USD Million (2021-2026)
  • Figure 38. Global Antibiotics Active Pharmaceutical Ingredient: by Application USD Million (2021-2026)
  • Figure 39. South America Antibiotics Active Pharmaceutical Ingredient Share (%), by Country
  • Figure 40. Asia Pacific Antibiotics Active Pharmaceutical Ingredient Share (%), by Country
  • Figure 41. Europe Antibiotics Active Pharmaceutical Ingredient Share (%), by Country
  • Figure 42. MEA Antibiotics Active Pharmaceutical Ingredient Share (%), by Country
  • Figure 43. North America Antibiotics Active Pharmaceutical Ingredient Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Sandoz International GmbH (Germany)
  • Centrient Pharmaceuticals (The Netherlands)
  • CordenPharma International (Germany)
  • ACS Dobfar S.p.A. (Italy)
  • Nanjing Dorra Pharmaceutical Technology Co. Ltd. (China)
  • Daewoong Pharmaceutical Co., Ltd (South Korea)
  • Parabolic Drugs Ltd. (India)
  • Penam Laboratories Ltd. (India)
  • Asiatic Drugs & Pharmaceuticals (India)
  • Fresenius Kabi (Germany)
  • United Laboratories Internat (Hong Kong)
Additional players considered in the study are as follows:
Aurobindo Pharma Limited (India) , Unimark Remedies Ltd. (India) , Savior Lifetec Corporation (Taiwan)
Select User Access Type

Key Highlights of Report


Apr 2021 225 Pages 76 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Antibiotics Active Pharmaceutical Ingredient Market Quantitative research analysis
Global Antibiotics Active Pharmaceutical Ingredient Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increased Prevalence of Bacterial Diseases " is seen as one of major growth factors of Antibiotics Active Pharmaceutical Ingredient Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Antibiotics Active Pharmaceutical Ingredient Market Report?

Have a Query? Click Here

Other Related Reports

Levothyroxine Sodium Tablet Comprehensive Study by Application (Hospital, Specialty Clinic), Treatment (Goiters, Thyroid cancer), Packaging (Bottle, Blister), Dosage (25mcg – 50mcg, 50mcg – 75mcg, 75...
$ 3350
Trulicity Comprehensive Study by Distribution Channel (Specialty Pharma Retail Stores, Hospitals Pharma), Dosage (Less than 1mg, 1mg - 2mg, 2mg - 3mg, 3mg - 4mg, More than 4mg) Players and Region - G...
$ 3500
Rilonacept Drugs Comprehensive Study by Application (Pediatric, Adult, Geriatric), Treatment (Familial Cold Urticaria Syndrome (FCUS), Muckle-Wells Syndrome (MWS), Neonatal Onset Multisystem Inflamma...
$ 3450
Cannabis Indica Oil Comprehensive Study by Type (Organic Cannabis Oil, Non-Organic Cannabis Oil), Application (Recreational, Medical) Players and Region - Global Market Outlook to 2026
$ 3500
Morphine Hydrochloride Comprehensive Study by Application (Pain Management, Diarrhea Suppressant, Cold and Cough Suppressant, Other), Drug Type (Anesthesia, Cough Suppressant, Diarrhea Suppressant, O...
$ 3450
Antihypertensives Comprehensive Study by Type (Diuretics, Angiotensin Converting Enzyme (ACE) Inhibitors, Angiotensin Receptor Blockers (ARBs), Beta Blockers, Vasodilators, Alpha Blockers, Renin Inhi...
$ 3650